Non-small Cell Lung Cancer with Superior Vena Cava Syndrome Effectively Treated with Implantation of Intravascular Stent and Chemotherapy--A Case Report and Review of the Literature

Superior vena cava syndrome is caused by obstruction of the superior vena cava due to a variety of malignant and benign entities. The most common malignant entities are lung cancer and mediastinal tumor. Conventional treatments include bypass surgery, external beam radiation therapy, chemotherapy, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Cardiologica Sinica 2005-01, Vol.21 (1), p.49-53
Hauptverfasser: 張雲德(Chong, Jun-ted), 吳榮州(Wu, Jung-chou), 張志賢(Chang, Chih-hsien), 薛爾榮(Hsueh, Erh-jung)
Format: Artikel
Sprache:chi
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 53
container_issue 1
container_start_page 49
container_title Acta Cardiologica Sinica
container_volume 21
creator 張雲德(Chong, Jun-ted)
吳榮州(Wu, Jung-chou)
張志賢(Chang, Chih-hsien)
薛爾榮(Hsueh, Erh-jung)
description Superior vena cava syndrome is caused by obstruction of the superior vena cava due to a variety of malignant and benign entities. The most common malignant entities are lung cancer and mediastinal tumor. Conventional treatments include bypass surgery, external beam radiation therapy, chemotherapy, and medical treatment. In this report, we performed an intravascular metallic stent deployment and combined chemotherapy with Vinorelbine in a case of non-small cell lung cancer with superior vena cava syndrome. The tumor regressed and symptomatic improvement was achieved after 124 days of follow-up. However, stent migration was noted and possibly due to tumor shrinkage and subsequent luminal enlargement. The choice of stent size is critical and should allow for possibility of tumor regression.
format Article
fullrecord <record><control><sourceid>hyweb</sourceid><recordid>TN_cdi_hyweb_hyread_00085372</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00085372</sourcerecordid><originalsourceid>FETCH-hyweb_hyread_000853723</originalsourceid><addsrcrecordid>eNqFjsFqwzAQRHVooaHNH_SwP2CQnTpJj8WkNBB6iEOuYWOvK4EsGWltow_r_1Ulvfcyc3gzw9yJRS7zPFtvX4oHsQxBX2W-LovXUm4W4vvT2Sz0aAxUlOQw2i-o0DbkYdasoB4H8tp5OJPFRCaEOtrWu55g13XUsJ7IRDh5Qqb2Vtr3g0HLyNpZcB3sLfvUDM1o0EPNZBnQtlAp6h0r8jjELHtL84HgSIPzN36kSdP8u5BCcNCckjx6ehL3HZpAyz9_FM_vu1P1kak40_WiYjrTXqSU23K1KVb_4B9c1l4g</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Non-small Cell Lung Cancer with Superior Vena Cava Syndrome Effectively Treated with Implantation of Intravascular Stent and Chemotherapy--A Case Report and Review of the Literature</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>張雲德(Chong, Jun-ted) ; 吳榮州(Wu, Jung-chou) ; 張志賢(Chang, Chih-hsien) ; 薛爾榮(Hsueh, Erh-jung)</creator><creatorcontrib>張雲德(Chong, Jun-ted) ; 吳榮州(Wu, Jung-chou) ; 張志賢(Chang, Chih-hsien) ; 薛爾榮(Hsueh, Erh-jung)</creatorcontrib><description>Superior vena cava syndrome is caused by obstruction of the superior vena cava due to a variety of malignant and benign entities. The most common malignant entities are lung cancer and mediastinal tumor. Conventional treatments include bypass surgery, external beam radiation therapy, chemotherapy, and medical treatment. In this report, we performed an intravascular metallic stent deployment and combined chemotherapy with Vinorelbine in a case of non-small cell lung cancer with superior vena cava syndrome. The tumor regressed and symptomatic improvement was achieved after 124 days of follow-up. However, stent migration was noted and possibly due to tumor shrinkage and subsequent luminal enlargement. The choice of stent size is critical and should allow for possibility of tumor regression.</description><description>上腔靜脈症候群是由於上腔靜脈阻塞或狹窄所引起,其肇因有惡性腫瘤或良性病灶。常見的惡性腫瘤主要是肺癌和縱隔腔腫瘤。治療模式必須根據其潛在病因。在傳統治療上,有外科燒道手術、體外放射線治療、化學治療及內科療法。根據過去的病例報告,本科為1位肺癌病患植入血管內支架及合併化療藥劑,成功有效減小腫瘤體積及解除症狀。然而,在後續追蹤卻發現支架移位現象,或由於腫瘤體積縮小以致血管擴大所致。因此,慎選支架大小並考慮腫瘤縮小可能的影響是非常重要的</description><identifier>ISSN: 1011-6842</identifier><language>chi</language><publisher>台灣: 中華民國心臟學會</publisher><subject>Intravascular stent ; MEDLINE ; SCI ; Scopus ; Superior vena cava syndrome ; 上腔靜脈症候群 ; 血管內支架</subject><ispartof>Acta Cardiologica Sinica, 2005-01, Vol.21 (1), p.49-53</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>張雲德(Chong, Jun-ted)</creatorcontrib><creatorcontrib>吳榮州(Wu, Jung-chou)</creatorcontrib><creatorcontrib>張志賢(Chang, Chih-hsien)</creatorcontrib><creatorcontrib>薛爾榮(Hsueh, Erh-jung)</creatorcontrib><title>Non-small Cell Lung Cancer with Superior Vena Cava Syndrome Effectively Treated with Implantation of Intravascular Stent and Chemotherapy--A Case Report and Review of the Literature</title><title>Acta Cardiologica Sinica</title><description>Superior vena cava syndrome is caused by obstruction of the superior vena cava due to a variety of malignant and benign entities. The most common malignant entities are lung cancer and mediastinal tumor. Conventional treatments include bypass surgery, external beam radiation therapy, chemotherapy, and medical treatment. In this report, we performed an intravascular metallic stent deployment and combined chemotherapy with Vinorelbine in a case of non-small cell lung cancer with superior vena cava syndrome. The tumor regressed and symptomatic improvement was achieved after 124 days of follow-up. However, stent migration was noted and possibly due to tumor shrinkage and subsequent luminal enlargement. The choice of stent size is critical and should allow for possibility of tumor regression.</description><description>上腔靜脈症候群是由於上腔靜脈阻塞或狹窄所引起,其肇因有惡性腫瘤或良性病灶。常見的惡性腫瘤主要是肺癌和縱隔腔腫瘤。治療模式必須根據其潛在病因。在傳統治療上,有外科燒道手術、體外放射線治療、化學治療及內科療法。根據過去的病例報告,本科為1位肺癌病患植入血管內支架及合併化療藥劑,成功有效減小腫瘤體積及解除症狀。然而,在後續追蹤卻發現支架移位現象,或由於腫瘤體積縮小以致血管擴大所致。因此,慎選支架大小並考慮腫瘤縮小可能的影響是非常重要的</description><subject>Intravascular stent</subject><subject>MEDLINE</subject><subject>SCI</subject><subject>Scopus</subject><subject>Superior vena cava syndrome</subject><subject>上腔靜脈症候群</subject><subject>血管內支架</subject><issn>1011-6842</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFjsFqwzAQRHVooaHNH_SwP2CQnTpJj8WkNBB6iEOuYWOvK4EsGWltow_r_1Ulvfcyc3gzw9yJRS7zPFtvX4oHsQxBX2W-LovXUm4W4vvT2Sz0aAxUlOQw2i-o0DbkYdasoB4H8tp5OJPFRCaEOtrWu55g13XUsJ7IRDh5Qqb2Vtr3g0HLyNpZcB3sLfvUDM1o0EPNZBnQtlAp6h0r8jjELHtL84HgSIPzN36kSdP8u5BCcNCckjx6ehL3HZpAyz9_FM_vu1P1kak40_WiYjrTXqSU23K1KVb_4B9c1l4g</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>張雲德(Chong, Jun-ted)</creator><creator>吳榮州(Wu, Jung-chou)</creator><creator>張志賢(Chang, Chih-hsien)</creator><creator>薛爾榮(Hsueh, Erh-jung)</creator><general>中華民國心臟學會</general><scope>9RA</scope></search><sort><creationdate>200501</creationdate><title>Non-small Cell Lung Cancer with Superior Vena Cava Syndrome Effectively Treated with Implantation of Intravascular Stent and Chemotherapy--A Case Report and Review of the Literature</title><author>張雲德(Chong, Jun-ted) ; 吳榮州(Wu, Jung-chou) ; 張志賢(Chang, Chih-hsien) ; 薛爾榮(Hsueh, Erh-jung)</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-hyweb_hyread_000853723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2005</creationdate><topic>Intravascular stent</topic><topic>MEDLINE</topic><topic>SCI</topic><topic>Scopus</topic><topic>Superior vena cava syndrome</topic><topic>上腔靜脈症候群</topic><topic>血管內支架</topic><toplevel>online_resources</toplevel><creatorcontrib>張雲德(Chong, Jun-ted)</creatorcontrib><creatorcontrib>吳榮州(Wu, Jung-chou)</creatorcontrib><creatorcontrib>張志賢(Chang, Chih-hsien)</creatorcontrib><creatorcontrib>薛爾榮(Hsueh, Erh-jung)</creatorcontrib><collection>HyRead台灣全文資料庫</collection><jtitle>Acta Cardiologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>張雲德(Chong, Jun-ted)</au><au>吳榮州(Wu, Jung-chou)</au><au>張志賢(Chang, Chih-hsien)</au><au>薛爾榮(Hsueh, Erh-jung)</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-small Cell Lung Cancer with Superior Vena Cava Syndrome Effectively Treated with Implantation of Intravascular Stent and Chemotherapy--A Case Report and Review of the Literature</atitle><jtitle>Acta Cardiologica Sinica</jtitle><date>2005-01</date><risdate>2005</risdate><volume>21</volume><issue>1</issue><spage>49</spage><epage>53</epage><pages>49-53</pages><issn>1011-6842</issn><abstract>Superior vena cava syndrome is caused by obstruction of the superior vena cava due to a variety of malignant and benign entities. The most common malignant entities are lung cancer and mediastinal tumor. Conventional treatments include bypass surgery, external beam radiation therapy, chemotherapy, and medical treatment. In this report, we performed an intravascular metallic stent deployment and combined chemotherapy with Vinorelbine in a case of non-small cell lung cancer with superior vena cava syndrome. The tumor regressed and symptomatic improvement was achieved after 124 days of follow-up. However, stent migration was noted and possibly due to tumor shrinkage and subsequent luminal enlargement. The choice of stent size is critical and should allow for possibility of tumor regression.</abstract><abstract>上腔靜脈症候群是由於上腔靜脈阻塞或狹窄所引起,其肇因有惡性腫瘤或良性病灶。常見的惡性腫瘤主要是肺癌和縱隔腔腫瘤。治療模式必須根據其潛在病因。在傳統治療上,有外科燒道手術、體外放射線治療、化學治療及內科療法。根據過去的病例報告,本科為1位肺癌病患植入血管內支架及合併化療藥劑,成功有效減小腫瘤體積及解除症狀。然而,在後續追蹤卻發現支架移位現象,或由於腫瘤體積縮小以致血管擴大所致。因此,慎選支架大小並考慮腫瘤縮小可能的影響是非常重要的</abstract><cop>台灣</cop><pub>中華民國心臟學會</pub></addata></record>
fulltext fulltext
identifier ISSN: 1011-6842
ispartof Acta Cardiologica Sinica, 2005-01, Vol.21 (1), p.49-53
issn 1011-6842
language chi
recordid cdi_hyweb_hyread_00085372
source EZB-FREE-00999 freely available EZB journals
subjects Intravascular stent
MEDLINE
SCI
Scopus
Superior vena cava syndrome
上腔靜脈症候群
血管內支架
title Non-small Cell Lung Cancer with Superior Vena Cava Syndrome Effectively Treated with Implantation of Intravascular Stent and Chemotherapy--A Case Report and Review of the Literature
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A13%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hyweb&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-small%20Cell%20Lung%20Cancer%20with%20Superior%20Vena%20Cava%20Syndrome%20Effectively%20Treated%20with%20Implantation%20of%20Intravascular%20Stent%20and%20Chemotherapy--A%20Case%20Report%20and%20Review%20of%20the%20Literature&rft.jtitle=Acta%20Cardiologica%20Sinica&rft.au=%E5%BC%B5%E9%9B%B2%E5%BE%B7(Chong,%20Jun-ted)&rft.date=2005-01&rft.volume=21&rft.issue=1&rft.spage=49&rft.epage=53&rft.pages=49-53&rft.issn=1011-6842&rft_id=info:doi/&rft_dat=%3Chyweb%3E00085372%3C/hyweb%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true